Thomas Swalla

Thomas Swalla is CEO and board director at Dotmatics, leading a team of 800 mission-driven scientists and employees who are focused on helping scientists make the world a healthier, cleaner, safer place to live.

3 things to understand how AI might help develop new, cost-effective drug treatments

OPINION September 22

3 things to understand how AI might help develop new, cost-effective drug treatments

3 things to understand how AI might help develop new, cost-effective drug treatments. Artificial intelligence success won't happen fast, but industry is well-positioned.

AI is a shot in the arm for better medicine

OPINION August 4

AI is a shot in the arm for better medicine

AI will help researchers predict how drugs will interact, their toxicity, and potential inhibitions. New successful compounds will be identified more quickly and cost-effectively.